Not provided
Not provided
Not provided
Not provided
Too many eligible patients who did not want to participate, very low inclusion rate
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Radboud University Medical Center | OTHER |
Not provided
Not provided
Not provided
Not provided
Rationale: It is well established that tobacco use has severe health consequences. The prevalence of Tobacco Use Disorder (TUD) is among the highest in populations with Substance Use Disorders (SUD). Despite behavioral and pharmacological treatment options, relapse rates remain high. Therefore, there is a need for additional smoking cessation treatment options that aid long-term abstinence.
A potential interesting intervention is addiction-focused Eye Movement Desensitization and Reprocessing (AF-EMDR) therapy. However, the limited research on AF-EMDR therapy and mixed findings thus far prohibit clinical use. Recently, on the basis of diverse findings thus far, an adjusted AF-EMDR protocol has been developed.
SUMMARY
Rationale: It is well established that tobacco use has severe health consequences. The prevalence of Tobacco Use Disorder (TUD) is among the highest in populations with Substance Use Disorders (SUD). Despite behavioral and pharmacological treatment options, relapse rates remain high. Therefore, there is a need for additional smoking cessation treatment options that aid long-term abstinence.
A potential interesting intervention is addiction-focused Eye Movement Desensitization and Reprocessing (AF-EMDR) therapy. However, the limited research on AF-EMDR therapy and mixed findings thus far prohibit clinical use. Recently, on the basis of diverse findings thus far, an adjusted AF-EMDR protocol has been developed.
Objective: to investigate areas of uncertainty about a possible future definitive RCT using AF-EMDR as an add-on intervention to a Smoking Cessation Program (SCP), by determining:
Study design: a pilot study with a two-armed randomized controlled design is used in which AF-EMDR + Treatment As Usual (TAU) (Community Reinforcement Approach (CRA) aimed at SUD + a SCP) is contrasted with TAU-only with an intervention phase of three weeks pre- and post intervention assessments and a follow-up after one and three months.
Study population: daily smoking adults, admitted to an inpatient addiction care clinic. A total of 50 eligible participants will be allocated at random to one of two treatment groups.
- In order to be eligible, patients must meet the following criteria: 1) age ≥ 18 years, 2) good Dutch language proficiency, 3) a DSM-5 diagnosis of Tobacco Use Disorder, 4) smoking, on average, ≥ 10 cigarettes per day pre-admission, 5) A score of at least 5 on a scale from 0 to 10, for motivation and self-efficacy, 6) a planned inpatient stay of ≥ 4 weeks, and 7) written informed consent.
Respondents who demonstrate serious therapy interfering behavior or symptoms that also interfere with TAU will be excluded from participation in this study (e. g. psychiatric or medical crisis that requires immediate intervention).
Intervention: a total of six 45-90 min. sessions of AF-EMDR twice per week added to a SCP embedded in TAU.
Main study parameters/endpoints:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TAU only: Community Reinforcement Approach (CRA) + a regular smoking cessation program | Active Comparator | TAU only |
|
| TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR) + TAU (CRA) | Experimental | TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR) | Behavioral | A total of six 45-90 min. sessions of AF-EMDR therapy with an average frequency of twice per week added to a SCP embedded in CRA. AF-EMD therapy consists of a rationale, installating a treatment goal, desensitasing mental video's, installation of positive cognition, future template and positive ending. |
| Measure | Description | Time Frame |
|---|---|---|
| Retention of participants | The retention of participants from randomization until the last follow-up. | 1 year |
| Acceptability in terms of compliance | The acceptability of AF-EMDR to participants in terms of compliance, measured by the total number of sessions attended and the proportion of attended versus non attended (planned) sessions; a higher proportion of attended sessions reflects better compliance. | 1 year |
| Acceptability in terms of adherence | The acceptability of AF-EMDR to therapists in terms of adherence to the protocol, measured by the score of an independent rater on a self-developed, a-priori established adherence rating protocol using 47 Likert-type items (range 1-5); a higher score reflects better adherence. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of participants | The proportion of patients at the clinic that are potentially eligible and provide informed consent. | 1 year |
| The feasibility of the outcome measures | The feasibility of the outcome measures in terms of completion of questionnaires (% per questionnaire and total). |
| Measure | Description | Time Frame |
|---|---|---|
| Demographics | Demographics, as inventoried by a structured interview and patient files. | 1 year |
| Smoking history | Smoking (cessation history), inventoried by a structured interview and patient files. |
Inclusion Criteria:
Exclusion Criteria:
• Serious therapy interfering behavior or symptoms that also interfere with TAU, based on clinical judgement (e. g. psychiatric or medical crisis that requires immediate intervention).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Addiction clinic 'Tiel' IrisZorg | Tiel | Gelderland | 4001 AG | Netherlands |
Depending on the final data collection and the journal in which these are published, we will decide on availability of IPD
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014029 | Tobacco Use Disorder |
| D016739 | Behavior, Addictive |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D003192 | Compulsive Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D054832 | Urocortins |
| ID | Term |
|---|---|
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D009479 | Neuropeptides |
Not provided
Not provided
Study design: a pilot study with a two-armed randomized controlled design is used in which AF-EMDR + Treatment As Usual (TAU) (Community Reinforcement Approach (CRA) aimed at SUD + a SCP) is contrasted with TAU-only with an intervention phase of three weeks pre- and post intervention assessments and a follow-up after one and three months.
Not provided
Not provided
Not provided
Not provided
|
|
| TAU only: Community Reinforcement Approach (CRA) + SCP | Behavioral | CRA is a comprehensive cognitive behavioural treatment that focuses on helping people discover and adopt a pleasurable, social and healthy lifestyle that is more rewarding than a lifestyle including substance use. Within CRA a regular smoking cessation program is embedded. |
|
|
| 1 year |
| Missing data | Amount of missing data, measured by total number of missing values and the proportion of completed versus missing data. | 1 year |
| 1 year |
| DSM-5 | Current DSM-5 diagnoses, inventoried by a structured interview and patient files. | 1 year |
| Motivation | Motivation to quit smoking, measured by a Likert-type scale from 0 to 10; a higher score reflects a higher motivation. | 1 year |
| Self-efficacy | Smoking cessation self-efficacy, measured by a Likert-type scale from 0 to 10; a higher score reflects a higher self-efficacy. | 1 year |
| Nicotine dependence | Severity of nicotine dependence, measured by the Fagerström Test of Nicotine Dependence, providing a score from 0 to 10; a higher score reflects a more severe dependence. | 1 year |
| Time to relapse | Time to relapse (from the end of the AF-EMDR intervention, if abstinence is achieved), measured in number of days from the end of the AF-EMDR intervention until first cigarette smoked. The higher the number of days, the longer the time to relapse. | 1 year |
| Smoking behavior | Changes from baseline (T0) to T1-T2-T3 in: Smoking behavior, measured by mean number of cigarettes smoked per day over the past 7 days; a higher score means a worse outcome. | 1 year |
| Tobacco craving | Changes from baseline (T0) to T1-T2-T3 in: Tobacco craving, as measured by the total score on the Questionnaire of Smoking Urges - Brief version; a higher score means a worse outcome. | 1 year |
| Craving related self-control/self-efficacy | Changes from baseline (T0) to T1-T2-T3 in: Craving related self-control/self-efficacy. As measured by a five-item subscale of the Self-control cognitions Questionnaire Likertscales, range 1-5, min 5, max 25); a higher score means a worse outcome. | 1 year |
| Positive incentive value | Changes from baseline (T0) to T1-T2-T3 in: Positive incentive value. As measured by a six-item subscale of the Self-control cognitions Questionnaire (Likert-type scales, range 1-5, min. score 6, max 30); a higher score means a worse outcome. | 1 year |
| Level of Urge | Within AF-EMDR session changes in: Mean Level of Urge, measured by a Likert-type scale from 0 to 10; a higher score means a worse outcome. | 1 year |
| Level of Positive Affect | Within AF-EMDR session changes in: Mean Level of Positive Affect, measured by a Likert-type scale from 0 to 10; a higher score means a worse outcome | 1 year |
| D007175 | Impulsive Behavior |
| D001519 | Behavior |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |